Clinical trial
Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast…
NCT00213980 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00213980 |
|---|---|
| Title | Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer |
| Official title | Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Zoledronate |
| Enrollment | 68 |
| Start date | Jan 1, 2000 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 27, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: